Management of Retroperitoneal Paraganglioma

Initial Approach and Diagnosis

Thorough preoperative cross-sectional nuclear medicine evaluation should be performed to identify potential multifocality, which is common in patients with paragangliomas 2, 3
Diagnostic workup should include cross-sectional imaging (CT/MRI) to determine tumor size, location, and vascular involvement 4

Biochemically positive paragangliomas should be resected as an initial priority in patients with multifocal disease to prevent perioperative hypertensive crisis 2, 5
Preoperative angiography with embolization should be considered for tumors with significant vascular involvement 6
Balloon occlusion testing is recommended when major vessel sacrifice with reconstruction might be necessary 6

Open surgical approach is recommended for tumors >5-6 cm to allow assessment of locoregional nodal disease 1, 7
Complete resection is essential, as overall survival is higher in patients with complete tumor resection compared to medical management alone 1, 2
Special considerations for retroperitoneal paragangliomas include the potential for local invasion with major vessel involvement, requiring vascular reconstruction 1, 4
Safe resection requires manual assessment, palpation, careful retraction, and ability to cross-clamp large vessels 7, 8

Follow-up assessment should include clinical evaluation and cross-sectional imaging 9
Initial follow-up intervals should be shorter (3-6 months) and can extend to annual after 5 years 9
Cross-sectional imaging can detect asymptomatic recurrences before symptoms develop 9

Palliative debulking has a limited role but can be considered in patients with locally aggressive, large tumors with high probability of incomplete surgical resection 3
Potential complications to monitor include perioperative hemodynamic instability requiring experienced anesthesiologists 1
Sexual dysfunction in patients with pelvic paragangliomas, particularly in males, which should be discussed preoperatively 7, 8
For recurrent disease, surgical intervention should be considered on an individualized basis within a specialist sarcoma multidisciplinary team, considering factors such as age, histological subtype, tumor grade, multifocality, disease-free interval, and previous treatment 9